CENTRAL PHARMA BIOTECHNICA LIMITED
Company number 13182798
- Company Overview for CENTRAL PHARMA BIOTECHNICA LIMITED (13182798)
- Filing history for CENTRAL PHARMA BIOTECHNICA LIMITED (13182798)
- People for CENTRAL PHARMA BIOTECHNICA LIMITED (13182798)
- More for CENTRAL PHARMA BIOTECHNICA LIMITED (13182798)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
14 Nov 2024 | AA | Accounts for a small company made up to 31 December 2023 | |
21 Jan 2024 | CS01 | Confirmation statement made on 4 January 2024 with no updates | |
14 Nov 2023 | AA | Audit exemption subsidiary accounts made up to 31 December 2022 | |
13 Nov 2023 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 31/12/22 | |
11 Oct 2023 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/22 | |
11 Oct 2023 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/22 | |
25 Apr 2023 | DISS40 | Compulsory strike-off action has been discontinued | |
24 Apr 2023 | AA | Accounts for a small company made up to 31 December 2021 | |
11 Apr 2023 | GAZ1 | First Gazette notice for compulsory strike-off | |
26 Jan 2023 | CS01 | Confirmation statement made on 4 January 2023 with no updates | |
26 Jan 2023 | AP01 | Appointment of Mr Schalk Willem De Beer as a director on 28 March 2022 | |
01 Apr 2022 | AA01 | Previous accounting period shortened from 28 February 2022 to 31 December 2021 | |
01 Apr 2022 | CS01 | Confirmation statement made on 4 January 2022 with no updates | |
05 Feb 2021 | NEWINC |
Incorporation
Statement of capital on 2021-02-05
|